RecruitingNot ApplicableNCT05830305

MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors


Sponsor

The University of Hong Kong

Enrollment

140 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial investigates the efficacy and safety of mobile health intervention in managing hypertension after Intracerebral Hemorrhage (ICH).


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria3

  • Primary ICH Diagnosis
  • Age ≥ 18 years
  • Discharge Modified Rankin Scale of ≤4

Exclusion Criteria10

  • Expected life expectancy of \<1 year
  • Patient or caregiver does not have access to WeRISE App.
  • Patient or caregiver does not know how to use WeRISE App .
  • Inability to perform home BP monitoring
  • Inability to participate in follow-up activity
  • Contraindication for intensive and rapid lowering of blood pressure (Known \>70% cerebral vascular stenosis; History of fall, dizziness or syncope due to hypotension; Any other medical condition that is deemed contraindicated for low blood pressure
  • Bleeding tendency (Platelet count \< 75 x 10\^9/L; Known coagulation disorder)
  • Severe renal impairment (Estimated glomerular filtration rate using CKD-EPI formula \<30 ml/min/1.73m2)
  • Severe liver impairment (Child-Pugh C cirrhosis)
  • Known contraindication or allergy to two or more anti-hypertensive classes

Interventions

OTHERMobile health intervention

A protocol-based intervention via phone calls, which includes anti-hypertensive drug adjustment and reinforcement of lifestyle modification, will be implemented.


Locations(1)

Queen Mary Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05830305


Related Trials